🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label, single-dose, sequential group study to compa...
Status
Completed
Location
Advanced Pharma - Miami
Start Date
2024-04-17
Trial ID
NCT03896750
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of PA...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-12
Trial ID
NCT01768273
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2015-02
Trial ID
NCT02342886
This study is a Phase 1, single-center, open-label, single-dose study to ev...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2006-03
Trial ID
NCT03202693
Treatments Being Tested
This is a single-dose, open-label, randomized, four-period, four-treatment,...
Status
Completed
Location
Worldwide Clinical Trials Early Phase Services, LLC
Start Date
2020-01-14
Trial ID
NCT04309656
Treatments Being Tested
The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Status
Completed
Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Start Date
2012-10
Trial ID
NCT01691534
Treatments Being Tested
To evaluate the efficacy, safety and tolerability of various doses and dura...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2017-11-21
Trial ID
NCT03086486
Treatments Being Tested
The goal of this clinical trial is to evaluate 3 dose levels of TBAJ876 for...
Status
Active Not Recruiting
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2023-10-31
Trial ID
NCT06058299
Treatments Being Tested
The purpose of this study is to determine the mycobactericidal activity of ...
Status
Completed
Location
The Aurum Institute: Tembisa Hospital
Start Date
2014-10-23
Trial ID
NCT02193776
This is a Phase 1, single-center, randomized, balanced, single-dose, two-tr...
Status
Completed
Location
MDS Pharma Services
Start Date
2007-03
Trial ID
NCT01828827
Treatments Being Tested